CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY. Mediterr J Hematol Infect Dis 2010, 2 (2), e2010020. https://doi.org/10.4084/mjhid.2010.020.